A new therapy for treating breast cancer could increase life expectancy by 50 percent for sufferers. T-DM1 has been praised by cancerologists for its effectiveness at fighting cancer with minimal side-effects. T-DM1 gives a survival advantage of 65 percent after two years of therapy.
